Björn Pilebro
- Co-authors
- Per LindqvistOle B. SuhrTorbjörn SundströmPer WestermarkKrister LindmarkIntissar AnanUlf NäslundJonas Wixner
- Topics
- Amyloidosis: Diagnosis, Treatment, Outcomes (26 papers)Parathyroid Disorders and Treatments (11 papers)Cardiovascular Function and Risk Factors (9 papers)
- Partner nations
- SwedenDenmarkUnited States
In The Last Decade
Björn Pilebro
25 papers receiving 511 citations
Hit Papers
Peers
Comparison fields: 5 of 42
- Molecular Biology 449
- Nephrology 217
- Cardiology and Cardiovascular Medicine 109
- Oncology 102
- Physiology 101
Countries citing papers authored by Björn Pilebro
This map shows the geographic impact of Björn Pilebro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Björn Pilebro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Björn Pilebro more than expected).
Fields of papers citing papers by Björn Pilebro
This network shows the impact of papers produced by Björn Pilebro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Björn Pilebro. The network helps show where Björn Pilebro may publish in the future.
Co-authorship network of co-authors of Björn Pilebro
This figure shows the co-authorship network connecting the top 25 collaborators of Björn Pilebro. A scholar is included among the top collaborators of Björn Pilebro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Björn Pilebro. Björn Pilebro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathybreakdown → | 41 |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 8 | |
| 7 | 9 | |
| 8 | 0 | |
| 9 | [Hereditary transthyretin amyloidosis - from symptomatic to curative treatment?] | 1 |
| 10 | 6 | |
| 11 | 12 | |
| 12 | 12 | |
| 13 | 30 | |
| 14 | 59 | |
| 15 | 17 | |
| 16 | 2 | |
| 17 | 83 | |
| 18 | 75 | |
| 19 | 14 | |
| 20 | 30 |
About Björn Pilebro
Björn Pilebro is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Rheumatology, having authored 28 papers that have together received 516 indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (26 papers), Parathyroid Disorders and Treatments (11 papers) and Cardiovascular Function and Risk Factors (9 papers). The work is most often cited by research in Nephrology (217 citations), Molecular Biology (449 citations) and Rheumatology (78 citations). Björn Pilebro has collaborated with scholars based in Sweden, Denmark and United States. Frequent co-authors include Per Lindqvist, Ole B. Suhr, Torbjörn Sundström, Per Westermark, Krister Lindmark, Intissar Anan, Ulf Näslund, Jonas Wixner, Jens Sørensen and Gunnar Antoni. Their work appears in journals such as New England Journal of Medicine, PLoS ONE and Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.